当前位置: 首页 > 期刊 > 《中国中医药信息杂志》 > 2018年第10期
编号:13273524
参苓白术散对非酒精性脂肪性肝病模型大鼠瘦素及胰岛素抵抗的影响(5)
http://www.100md.com 2018年10月1日 《中国中医药信息杂志》 2018年第10期
     [19] RODRIGUEZ-ECHEVARRIA R, MACIAS-BARRAGAN J, PARRA-VARGAS M, et al. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice[J]. World J Gastroenterol, 2018,24(4):461-474.

    [20] POLYZOS S A, KOUNTOURAS J, ZAVOS C. Nonalcoholic fatty liver disease:the pathogenetic roles of insulin resistance and adipocytokines[J]. Curr Mol Med,2009,9(3):299-314.

    [21] ALHASSON F, SETH R K, SARKAR S, et al. High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease[J]. Redox Biol,2018,17:1-15.

    [22] VENIAMINOVA E, CESPUGLIO R, CHEUNG C W, et al. Autism-like behaviours and memory deficits result from a western diet in mice[J]. Neural Plast,2017,2017:9498247.

    [23] VALENTINI D, ALISI A, DI CAMILLO C, et al. Nonalcoholic fatty liver disease in italian children with down syndrome:prevalence and correlation with obesity-related features[J]. J Pediatr, 2017,189:92-97.

    [24] POLYZOS S A, KOUNTOURAS J, ZAVOS C, et al. The potential adverse role of leptin resistance in nonalcoholic fatty liver disease:A hypothesis based on critical review of literature[J]. Clin Gastroenterol,2010,45(1):50-54., 百拇医药(王萌 张会存 刘欣 汪红兵)
上一页1 2 3 4 5